Nasopharyngeal carcinoma pathophysiology
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma pathophysiology On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma pathophysiology |
Risk calculators and risk factors for Nasopharyngeal carcinoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
On microscopic histopathological analysis, abundant dense eosinophilic cytoplasm and prominent lymphoid component are characteristic findings of nasopharyngeal carcinoma.
Pathology
Nasopharyngeal carcinoma may be classified according to microscopic features into 3 subtypes:[1]
- Well-differentiated (keratinizing type)
- Moderately-differentiated (nonkeratinizing type)
- Undifferentiated (most strongly associated with Epstein-Barr virus infection)
-
Undifferentiated nasopharyngeal carcinoma - low power
-
Undifferentiated nasopharyngeal carcinoma - med. power
-
Undifferentiated nasopharyngeal carcinoma - high power
Gross
- Nasal cavity involvement - common in early disease[2]
Microscopic
Features:[3]
- Prominent lymphoid component - key feature
- Features of squamous cell carcinoma:
- Cohesive cells with:
- Abundant dense eosinophilic cytoplasm
- Central nuclei +/- small/indistinct nucleoli
- Cohesive cells with:
Immunohistochemistry
Immunohistochemistry stains for nasopharyngeal carcinoma include:
- EBER positive
- p16 negative[4]
References
- ↑ Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor). Modern Surgical Pathology (2 Volume Set). London: W B Saunders. ISBN 0-7216-7253-1.
- ↑ Abdel Khalek Abdel Razek, A.; King, A. (2012). "MRI and CT of nasopharyngeal carcinoma". AJR Am J Roentgenol. 198 (1): 11–8. doi:10.2214/AJR.11.6954. PMID 22194474. Unknown parameter
|month=
ignored (help) - ↑ Nasopharyngeal carcinoma http://librepathology.org/wiki/index.php/Nasopharyngeal_carcinoma
- ↑ Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY, Geradts J (1998). "Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product". Am. J. Pathol. 152 (4): 865–9. PMC 1858242. PMID 9546345. Unknown parameter
|month=
ignored (help)